Ultrasound study maps normal liver and spleen stiffness in kids
NCT ID NCT06930066
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study measured liver and spleen stiffness in 434 healthy children aged 0-18 using a non-invasive ultrasound technique called shear wave elastography. The goal was to establish normal reference values, which could help doctors better detect liver or spleen disease in children. No treatment was given; this was purely an observational study to improve diagnostic accuracy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study will provide normal reference values for liver and spleen stiffness in children, helping doctors better diagnose organ diseases using ultrasound.
- What could go wrong
- This is an observational study, not a treatment trial. It only establishes normal ranges and does not test any therapy or intervention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
434 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will consist of healthy children aged 0-18 years, with no known liver or spleen pathology. These participants will be selected from pediatric clinics, specifically those who are seeking routine healthy child check-ups and have no underlying diseases. Non-invasive shear wave elastography (SWE) will be used to assess normal liver and spleen stiffness values. Participants will be selected based on inclusion criteria of being free from any liver or spleen disease, and exclusion criteria will ensure that children with known hepatic or splenic conditions are not included. Parental or guardian consent will be obtained for each participant.
- Ages
-
1 month to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy children aged 0-18 years * No known liver or spleen pathology * Written informed consent obtained from parents or guardians Exclusion Criteria: * Known liver disease (e.g., hepatitis, cirrhosis) * Known spleen disease (e.g., splenomegaly) * Any history of liver or spleen disease * Age outside the 0-18 years range
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Liver stiffness are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Selçuk University Faculty of Medicine
Konya, Konya, 42130, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.